Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Coca-Cola Europacific Partners
CCEP
$49.3B
| $48.9M | 0.05% |
1,175,278
+6,084
| +0.5% | +$258K |
|
302
PUT
Bausch Health
BHC
$2.25B
| $48.6M | 0.05% |
3,388,200
+1,757,100
| +108% | +$26.6M |
|
303
CSX Corp
CSX
$93B
| $48.5M | 0.05% |
2,683,797
-232,581
| -8% | -$3.99M |
|
304
Lockheed Martin
LMT
$132B
| $48.4M | 0.05% |
155,879
+231
| +0.1% | +$68.9K |
|
305
PUT
Target
TGT
$65.6B
| $48.2M | 0.05% |
816,900
+477,200
| +140% | +$26.7M |
|
306
Biogen
BIIB
$30.7B
| $48.2M | 0.05% |
153,842
-55,128
| -26% | -$16.3M |
|
307
CALL
Applied Materials
AMAT
$398B
| $48.1M | 0.05% |
924,300
+631,400
| +216% | +$28.6M |
|
308
Ventas
VTR
$44.7B
| $48.1M | 0.05% |
738,854
+193,766
| +36% | +$13.1M |
|
309
Citizens Financial Group
CFG
$30.3B
| $48.1M | 0.05% |
1,269,649
+857,075
| +208% | +$30M |
|
|
310
CALL
Gilead Sciences
GILD
$163B
| $47.6M | 0.05% |
587,800
+189,200
| +47% | +$14.5M |
|
311
CALL
Amgen
AMGN
$209B
| $47.6M | 0.05% |
255,300
+52,300
| +26% | +$9.27M |
|
312
Cigna
CI
$76.1B
| $47.5M | 0.05% |
254,319
+20,319
| +9% | +$3.62M |
|
313
Western Digital
WDC
$184B
| $47.3M | 0.05% |
724,197
+217,599
| +43% | +$14.4M |
|
314
Equity Residential
EQR
$25.2B
| $47.2M | 0.05% |
715,192
+275,929
| +63% | +$18.5M |
|
315
Eli Lilly
LLY
$1.03T
| $47.1M | 0.05% |
551,085
+42,554
| +8% | +$3.49M |
|
316
T. Rowe Price
TROW
$25.6B
| $47.1M | 0.05% |
519,400
+120,109
| +30% | +$9.93M |
|
317
PUT
Walmart Inc
WMT
$884B
| $47M | 0.05% |
1,803,600
+177,000
| +11% | +$4.64M |
|
|
DFS
318
DELISTED
Discover Financial Services
DFS
| $47M | 0.05% |
728,438
+31,933
| +5% | +$1.94M |
|
319
PUT
Mondelez International
MDLZ
$80.5B
| $46.8M | 0.05% |
1,151,300
+839,600
| +269% | +$35.7M |
|
320
Morgan Stanley
MS
$330B
| $46.8M | 0.05% |
970,783
-591,848
| -38% | -$27.5M |
|
321
VanEck Oil Services ETF
OIH
$2.01B
| $46.5M | 0.05% |
89,256
+9,945
| +13% | +$4.78M |
|
322
PUT
Vanguard Real Estate ETF
VNQ
$39.4B
| $46.4M | 0.05% |
558,200
+525,600
| +1,612% | +$43.9M |
|
323
CALL
McDonald's
MCD
$191B
| $46.3M | 0.05% |
295,800
+122,300
| +70% | +$19.2M |
|
324
PUT
Omega Healthcare
OHI
$15B
| $45.9M | 0.05% |
1,439,700
+1,439,300
| +359,825% | +$46.1M |
|
|
AET
325
DELISTED
Aetna Inc
AET
| $45.9M | 0.05% |
288,706
+18,319
| +7% | +$2.86M |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.